Syneron Medical Ltd.
ELOS, the leading global aesthetic device company announced today,
jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has
dismissed its United States patent infringement lawsuit against EndyMed and
Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products.
EndyMed and its United States distributor, Eclipse Aesthetics, agreed to
immediately stop selling EndyMed's Fractional Skin Resurfacing Products in the
United States but may continue to service and support previously purchased
products and supply replacement electrodes for them.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in